session # j1 disseminating your ideas: a conversation with ......if \൴he educational material or...

25
Disseminating your ideas: A conversation with the editors of Families, Systems, and Health Nadiya Sunderji, M.D., M.P.H. Jodi Polaha, Ph.D. Colleen Fogarty, M.D. Larry Mauksch, M. Ed. Session # J1 CFHA 20 th Annual Conference October 18-20, 2018 Rochester, New York

Upload: others

Post on 16-Apr-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Disseminating your ideas: A conversation with the editors of Families, Systems, and Health

Nadiya Sunderji, M.D., M.P.H.Jodi Polaha, Ph.D.Colleen Fogarty, M.D.Larry Mauksch, M. Ed.

Session # J1

CFHA 20th Annual ConferenceOctober 18-20, 2018 • Rochester, New York

Presenter
Presentation Notes
Please insert the assigned session number (track letter, period number), i.e., A2a Please insert the TITLE of your presentation. List EACH PRESENTER who will ATTEND the CFHA Conference to make this presentation. You may acknowledge other authors who are not attending the Conference in subsequent slides.
Page 2: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Faculty DisclosureThe presenters of this session have NOT had any relevant financial relationships during the past 12 months.

Presenter
Presentation Notes
You must include ONE of the statements above for this session. CFHA requires that your presentation be FREE FROM COMMERCIAL BIAS. Educational materials that are a part of a continuing education activity such as slides, abstracts and handouts CANNOT contain any advertising or product‐group message. The content or format of a continuing education activity or its related materials must promote improvements or quality in health care and not a specific propriety business interest of a commercial interest. Presentations must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If the educational material or content includes trade names, where available trade names for products of multiple commercial entities should be used, not just trade names from a single commercial entity. Faculty must be responsible for the scientific integrity of their presentations. Any information regarding commercial products/services must be based on scientific (evidence‐based) methods generally accepted by the medical community.
Page 3: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Learning ObjectivesAt the conclusion of this session, the participant will be able to:

• Identify an idea or project they wish to disseminate, one challenge they have encountered and one strategy to overcome this challenge

• Describe the process from idea to publication, and common pitfalls that can arise at each stage

• Join a collegial community of authors and peer reviewers involved in Families, Systems, & Health

Presenter
Presentation Notes
Include the behavioral learning objectives you identified for this session
Page 4: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Introduction to FSH Editors

Jodi Polaha, Incoming

Nadiya Sunderji, Incoming

Colleen Fogarty, Outgoing

Larry Mauksch, Outgoing

Presenter
Presentation Notes
To us – 5 min Talk about our movement over the past 5 years to get more research happening in CFHA/ The field has made progress so we are increasing rigor
Page 5: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Introduction to You• What are your experiences to date with publishing?

• What challenges have you encountered?

• What are you hoping to learn in this session?

Presenter
Presentation Notes
10 min - audience provide input regarding their regarding level of experience, challenges encountered, and their personal learning objectives for participating in this session We want to know their learning objectives. If we have a lot of people, just hear from a few. By show of hands: how many are new to publishing, how many have seen a research project from beginning to end? How many have been rejected and been immobilized
Page 6: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

The Publication ProcessIdeas

• Inspiration• Ground in

existing literature

• Obtain needed resources

Conduct research

• Ethics• Study design

(science)• Data collection,

analysis• Synthesis,

interpretation

Disseminate

• Presentations (peer reviewed and non-)

• Writing• Submitting to

target journal• Revising,

resubmitting• Promoting

(post- public’n)

Presenter
Presentation Notes
Mini-Didactic (15 min) We are mainly focusing on the disseminate bucket but issues at any of these stages/steps will impede publication Obtain needed resources (time, team, funding, institutional support)
Page 7: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

The Publication Process: IdeasIdeas: Where do they come from?

The role of clinician innovator

The role of QI in initiating research

Academic-clinical-community-other collaborations

Ideas

Presenter
Presentation Notes
Common problems we see at this stage:
Page 8: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Common Concerns: Ideas◦ Ground ideas in the literature◦ Don’t misuse/abuse the literature (unethical/poor use of citations)◦ Thinly sliced – small value add◦ Narrow perspective (e.g. single discipline on a multidisciplinary

topic)◦ Vet ideas with collaborators / stakeholders from the start

(integrated KT)

FINER criteria: Interesting, Novel, Relevant

Ideas

Presenter
Presentation Notes
We have a responsibility to safeguard the science of the movement How come is it that we didn’t emphasize science more specifically – we didn’t want to intimidate people?
Page 9: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Common Concerns: Conducting ResearchEthical considerations

Weak methods◦ Justify your approach using accepted scientific frameworks and methodologies◦ Qualitative research – theoretical and informational/thematic saturation

Consider referring to reporting guidelines for the conduct of various types of research

FINER criteria: Feasible, Ethical

Conduct research

https://www.equator-network.org/

Presenter
Presentation Notes
Jodi what was your concern re: qualitative research? Suggestion to consider referring to reporting guidelines for conduct of different types of research (currently optional for FSH)
Page 10: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

The Publication Process: Dissemination1. Ask yourself:

• Who is the target audience you are trying to reach?

• What is the main message you want them to take away?

• What do you want them to know or do differently after reading your paper?

• Why should they care?

Answers influence: target journal, type of manuscript/format, intro & discussion

2. Make presentations: helps get feedback, frame the story

3. Consider reviewer guidelines

4. Get writing support, feedback from a non-author

Disseminate

Page 11: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Reviewer GuidelinesPurpose: honest commentary on the quality and originality of a paper and the paper’s interest to the readership of Families, Systems, and Health.

Process: confidential, single blinded.

Guidelines:•We expect clear and concise writing in each section of every manuscript so as to be understandable to a general audience.

•Be honest and kind.•Identify your concerns clearly and be sure they are consistent with your recommendations.•Include specific suggestions for how the paper/research could be improved.

Disseminate

Page 12: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Reviewer GuidelinesTitle—Does the title adequately and concisely capture the content of the paper?

Abstract—Does the abstract concisely and accurately provide a distillation of the main points of the paper?

Introduction—Do the authors provide a concise review of the relevant literature to date, with up to date references from primary sources cited? Is there an adequate “gap” statement? Is the concept of the paper unique and relevant?

Disseminate

Page 13: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Reviewer GuidelinesMethods

Are the methods rigorous and appropriate to the topic of inquiry?

Is there an appropriate human subjects protection statement?

Are the methods described appropriately?

Is there a need for specialized statistical review?

Is the sample size appropriate?

Are the statistical analyses appropriate for the study design?

For systematic reviews of the literature, do the authors describe a reproducible strategy to conduct a thorough search of appropriate databases, and did they describe explicit inclusion/exclusion criteria related to selection of the primary studies?

Disseminate

Page 14: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Reviewer GuidelinesResults—Are the relevant demographics described adequately? Do the results follow logically from the stated reason to do the project? Are the results clear and focused? Are tables and figures used appropriately to illustrate findings without being more than minimally redundant with the text?

Discussion— Do the results have clinical, educational, or system design value and to what extent are they generalizable? Does the discussion include implications for clinical or educational practice? Are the noted limitations that are accurate, plausible and comprehensive?

For conceptual papers, do the authors include a thorough literature review, and does the model advance the literature and potentially enhance clinical practice?

Disseminate

Page 15: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Disseminate

Page 16: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Common Concerns: Manuscripts◦ Appropriate for the journal◦ Adequate contribution:◦ Importance◦ Implications for health/health care

◦ Literature◦ Scientific methods - we are NOT only after ideas◦ Thinly sliced◦ Poor writing – wordy, passive or mixed active and passive (“the

passive voice is to be used only sparingly” ;)

Disseminate

Presenter
Presentation Notes
We have a responsibility to safeguard the science of the movement How come is it that we didn’t emphasize science more specifically – we didn’t want to intimidate people?
Page 17: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Revising ManuscriptsREAD THE COMMENTS OF REVIEWERS CAREFULLY. They’re not just what you have to do to get by and get it published. They are gifts.

How?

Breathe. Take a break. Come back to it.

Reorganize the reviewer feedback into manageable chunks (e.g. by section of the paper). This can help take the sting out of criticism and use it constructively.

Read the editor comments carefully as we may offer help to digest the feedback.

Respond to all of it

Disseminate

Presenter
Presentation Notes
We would all agree some of our most important learning is when we get this kind of feedback
Page 18: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Small Group CoachingWhat do you want to work on?

Some common challenges:

• Finding time

• Writer’s block

• Contextualizing your work in the existing literature

• Dealing with rejection, responding to reviewer feedback

Presenter
Presentation Notes
work and coaching regarding a self-identified challenge, e.g. finding time to write, situating work in the existing literature, identifying target journals, responding to reviewer feedback, dealing with rejection, etc. (20 mins) Each of us could take 25% of the group and provide consultation. If the group is small, we could pair up? - 3-4 people per group is a good number Idea is that you will share concerns and don’t have to verbalize duplicate concerns
Page 19: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Large Group DiscussionWhat have you learned or what new questions have surfaced for you?

What is one thing you might take home with you from this discussion?

Presenter
Presentation Notes
Large group reflections, Question and Answer period (10 mins) RECRUIT REVIEWERS GIVE OUT Cheryl’s email or sign up sheet?
Page 20: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Reviewing for FSHReviewing is a GREAT way to strengthen your academic writing

… and to be a part of our FSH community

Contact Cheryl Johnson at [email protected]

Page 21: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Contact Us!

Jodi Polaha, Incoming

Nadiya Sunderji, Incoming

Presenter
Presentation Notes
To us – 5 min Talk about our movement over the past 5 years to get more research happening in CFHA/ The field has made progress so we are increasing rigor
Page 22: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Conference ResourcesSlides and handouts shared in advance by our Conference Presenters are available on the CFHA website at http://www.cfha.net/?page=Resources_2018

Slides and handouts are also available on the mobile app.

Page 23: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

If we can develop this with a few good subheadings and ideas… could be a gift to audience.

Bibliography / Reference

Presenter
Presentation Notes
Continuing education approval now requires that each presentation include five references within the last 5 years. Please list at least FIVE (5) references for this presentation that are no older than 5 years. Without these references, your session may NOT be approved for CE credit.
Page 24: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Learning AssessmentA learning assessment is required for CE credit.

A question and answer period will be conducted at the end of this presentation.

Presenter
Presentation Notes
Please incorporate audience interaction through a brief Question & Answer period during or at the conclusion of your presentation. This component MUST be done in lieu of a written pre- or post-test based on your learning objectives to satisfy accreditation requirements.
Page 25: Session # J1 Disseminating your ideas: A conversation with ......If \൴he educational material or content includes trade names, where available trade names for products of multiple

Session Evaluation

Use the CFHA mobile app to complete the evaluation for this session.

Thank you!

Presenter
Presentation Notes
This should be the last slide of your presentation